Search results

Search tips
Showing 1 – 50 of 70 results.
Curated
Restricted

Naltrexone for Extended-Release Injectable Suspension (XR-NTX) for Opioid Dependent Released HIV-Positive Criminal Justice Populations (Project NEW HOPE), Connecticut and Massachusetts, 2011-2015 (ICPSR 39790)

Released/updated on: 2026-04-21
Geographic coverage: United States, Massachusetts, Connecticut
Time period: 2011-09-01--2015-08-31

This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project that involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

The specific aim for this study was to conduct a placebo-controlled, RCT of VIVITROL or (extended-release naltrexone) (XR-NTX 380mg) among HIV+ persons in jails and prisons meeting DSM-IV criteria for opioid dependence who are transitioning to the community. HIV treatment outcomes (HIV-1 RNA levels, CD4 count, HAART adherence, retention in care), substance abuse (time to relapse to opioid use, % opioid negative urines, opioid craving), adverse side effects and HIV risk behavior (sexual and drug-related risks) outcomes were compared in 150 recruited prisoners and jail detainees in CT and MA who were randomized 2:1 to either XR-NTX 380mg or XR-NTX-placebo. The primary outcome of interest was the proportion with a HIV-RNA less than 400 copies/mL at 6 months. Secondary outcomes included mean CD4 count, antiretroviral adherence, retention on HAART and in HIV care, HIV risk behaviors, time-to-relapse to opioid use, percent opioid negative urines, retention on XR-NTX 380mg and HIV quality of life. Primary and secondary outcomes were assessed for an additional 6 months after completion of the intervention.

Curated
Partially restricted
Simple Crosstabs

Mindful Body Awareness Training for Medication for Opioid Use Disorder (MOUD), Pacific Northwest, 2019-2024 (ICPSR 39235)

Released/updated on: 2025-06-19
Geographic coverage: United States
Time period: 2019-08-01--2024-01-31
The national opioid epidemic requires development of real-world evidence-based treatments for opioid use disorder, including adjuncts to Medication for Opioid Use Disorder (MOUD). Interventions are needed that address the complex needs of patients with opioid use disorder, which include substantial mental health co-morbidity and high rates of chronic pain. This study tested a mind-body intervention, Mindful Awareness in Body-oriented Therapy (MABT), as an adjunct to MOUD across multiple community outpatient clinical settings. MABT, a mindfulness-based intervention, addresses aspects of awareness, interoception, and regulation that may be associated with pain, mental health distress, and behavioral control that increase risk of relapse and poor treatment outcomes.
Curated
Simple Crosstabs

Improving Health and Employment Outcomes Through Workplace Opioid Policies, United States, 2022-2023 (ICPSR 38967)

Released/updated on: 2024-03-13
Geographic coverage: United States
Time period: 2022-06-30--2023-03-01
This study developed and tested the feasibility of implementing guidelines on workplace policies to reduce prescription opioid use, decrease chronic opioid use, promote recovery from opioid use disorder, and improve health-related employment outcomes. The researchers developed and tested these guidelines among construction workers. This project provided critical information to design and conduct a randomized trial to implement and evaluate insurance and employment policy guidelines among labor-management health funds in the building trades.

This study is also available on the HEAL Data Platform (study record HDP00331).

Curated
Partially restricted
Simple Crosstabs

Raising Healthy Children, Seattle Metropolitan Area, 2004-2011 (ICPSR 37584)

Released/updated on: 2020-03-31
Geographic coverage: Seattle, United States, Washington
Time period: 2004-01-01--2011-12-31
Raising Healthy Children, initially funded in 1993, is an etiologic study of the development of substance use, with a randomized test of a social development intervention to prevent drug misuse and promote positive youth development nested within it. The study originally included 1,040 individuals who were recruited from 10 schools in a suburban school district in the Northwest United States in 1993, when they were in first or second grade. This dataset is an extension of the original study and includes data collected when participants were ages 18, 21, and 24/25. These data focused on age 18 environmental risk and protective factors for substance misuse and addiction from family, school, peer, community, and individual domains, as well as tobacco, alcohol, and marijuana use frequency at ages 18, 21, and 24. Of the 1,040 participants in the study, 494 consented to have their data archived. Demographic information collected includes race, sex, household income, and parent education level.
Curated
Restricted

National Inmate Survey (NIS) - Jails: Alternative Survey Respondents Only, [United States], 2007-2009 (ICPSR 37010)

Released/updated on: 2019-12-19
Geographic coverage: United States
Time period: 2007-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. The data in this study focuses solely upon substance use and treatment from the "alternative" version of the survey.

These 6,577 respondents contained in this file who completed the "alternative" survey are the same 6,577 alternative respondents from the study National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37011).

Curated
Restricted

National Inmate Survey (NIS) - Prisons: Alternative Survey Respondents Only, [United States], 2007-2009 (ICPSR 37016)

Released/updated on: 2019-12-19
Geographic coverage: United States
Time period: 2007-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. The data in this study focuses solely upon substance use and treatment from the "alternative" version of the survey.

These 3,908 respondents contained in this file who completed the "alternative" survey are the same 3,908 alternative respondents from the study National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37017).

Curated
Restricted

Northwestern Juvenile Project (Cook County, Illinois), Follow-up 5, 2002-2006 (ICPSR 36949)

Released/updated on: 2019-04-04
Geographic coverage: United States, Chicago, Illinois
Time period: 2002-01-01--2006-12-31

This study contains data from the fifth follow-up interview of the Northwestern Juvenile Project (NJP), a longitudinal assessment of alcohol, drug, or mental service treatment needs of juvenile detainees. The fifth follow-up occurred approximately 6 years after the baseline interview and focused on studying the development and persistence of psychiatric disorders, related predictive variables, patterns of drug use, and other risk behaviors.

The project's aims included studying (1) development and persistence of alcohol, drug, and mental disorders and (2) pathways and patterns of risky behaviors. Changes in disorders over time were studied (including onset, remission, and recurrence), comorbidity, associated functional impairments, and the risk and protective factors related to these disorders and impairments. This study addressed patterns and sequences of the development of drug use and related variables, focusing on gender differences, racial/ethnic differences, the antecedents of these risky behaviors (risk and protective factors), and how these behaviors were interrelated.

The original sample included 1829 randomly selected youth, 1172 males and 657 females, then 10 to 18 years old, enrolled in the study as they entered the Cook County Juvenile Temporary Detention Center from 1995 to 1998. Among the sample were 1005 African Americans, 524 Hispanics, and 296 non-Hispanic white respondents. Participants were tracked from the time they left detention. All participants were eligible for the fifth follow-up interview. Re-interviews were conducted regardless of where respondents were living when their follow-up interview was due: in the community, correctional settings, or by telephone if they lived farther than two hours from Chicago.

Curated
Restricted

National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2007 (ICPSR 37009)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2007-01-01--2007-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 88 percent of the respondents completed modules through the survey of sexual victimization while the other 12 percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same 37,088 respondents who are in this data are also part of the 79,973 respondents from the study National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37011).

Curated
Restricted

National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37011)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2007-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 92 percent of the respondents completed modules through the survey of sexual victimization while the other eight percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same eight percent of respondents (n=6,577) who completed the alternative survey are the same 6,577 respondents from the study National Inmate Survey (NIS) - Jails: Alternative Survey Respondents Only, [United States], 2007-2009 (ICPSR 37010).

Curated
Restricted

National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2008-2009 (ICPSR 37012)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2008-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 95 percent of the respondents completed modules through the survey of sexual victimization while the other five percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same 42,885 respondents who are in this data are also part of the 79,973 respondents from the study National Inmate Survey (NIS) - Jails: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37011).

Curated
Restricted

National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2007 (ICPSR 37015)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2007-01-01--2007-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 88 percent of the respondents completed modules through the survey of sexual victimization while the other 12 percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same 19,404 respondents who are in this data are also part of the 46,595 respondents from the study National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37017).

Curated
Restricted

National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37017)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2007-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 92 percent of the respondents completed modules through the survey of sexual victimization while the other eight percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same eight percent of respondents (n=3,908) who completed the alternative survey are the same 3,908 respondents from the study National Inmate Survey (NIS) - Prisons: Alternative Survey Respondents Only, [United States], 2007-2009 (ICPSR 37016).

Curated
Restricted

National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2008-2009 (ICPSR 37018)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2008-01-01--2009-12-31

The National Inmate Survey (NIS) is part of the Bureau of Justice Statistics' (BJS) National Prison Rape Statistics Program, which gathers mandated data on the incidence and prevalence of sexual assault in correctional facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108- 79). Inmates are randomly assigned to receive either a survey of sexual victimization or a survey of mental and physical health, past drug and alcohol use, and treatment for substance abuse. About 94 percent of the respondents completed modules through the survey of sexual victimization while the other six percent completed modules through the alternative survey. However, the data in this study focuses solely upon substance use and treatment. No respondent answered questions about sexual victimization.

The same 27,191 respondents who are in this data are also part of the 46,595 respondents from the study National Inmate Survey (NIS) - Prisons: Full Survey Respondents, [United States], 2007-2009 (ICPSR 37017).

Curated
Restricted

National Survey of Youth in Custody Alternate, Supplemental Survey on Drug and Alcohol Use, [United States], 2008-2009, 2012 (ICPSR 37025)

Released/updated on: 2018-09-10
Geographic coverage: United States
Time period: 2008-01-01--2009-12-31, 2012-01-01--2012-12-31

The National Survey of Youth in Custody (NSYC) is part of the BJS National Prison Rape Statistics Program to gather mandated data on the incidence of prevalence of sexual assault in juvenile facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108-79). The Act requires a 10 percent sample of juvenile facilities to be listed by incidence of sexual assault. Data are collected directly from youth in a private setting using audio computer-assisted self interview (ACASI) technology with a touch-screen laptop and an audio feed to maximize inmate confidentiality and minimize literacy issues. The first year of collection includes nearly 200 juvenile facilities, with an estimated 10,000 completed interviews with youth.

The National Survey of Youth in Custody Alternate (NSYC-A) is a supplement to NSYC that collected information on drug and alcohol use by youth in juvenile facilities. The survey was divided into six sections. Section A collected background information, such as age, gender, education level, and whether respondent had stayed overnight in a facility or had forced sexual contact prior to current incarceration. Section B, Facility Perceptions and Victimization, is not included in this dataset. Section C, Drug Use, included whether the respondent had ever used specific types of drugs, frequency of use in the past and immediately before being taken into custody, source of drugs, and symptoms of drug abuse and dependence. Section D, Alcohol Use, captured alcohol dependence and abuse symptoms. Section E, Treatment, focused on drug or alcohol treatment programs respondent had attended prior to being taken into custody. Section F, Family and Peer Background is not included in this dataset.

Other items include weights variables and derived variables regarding DSM IV drug dependence symptoms, alcohol and drug use/dependence/abuse status, outliers/illogical responses, and categorized demographic variables.

Curated
Restricted

Northwestern Juvenile Project (Cook County, Illinois): Follow-up 2, 1999 - 2005 (ICPSR 36629)

Released/updated on: 2018-06-08
Geographic coverage: United States, Chicago, Illinois
Time period: 1977-01-01--2005-12-31

This study contains data from the second follow-up interview of the Northwestern Juvenile Project (NJP), a longitudinal assessment of alcohol, drug, or mental service treatment needs of juvenile detainees. This second follow-up occurred approximately 3.5 years after the baseline interview and focused on the development and persistence of psychiatric disorders, related predictive variables, patterns of drug use, and other risky behaviors.

The project's aims included studying (1) development and persistence of alcohol, drug, and mental disorders and (2) pathways and patterns of risky behaviors. Researchers studied changes in disorders over time (including onset, remission, and recurrence), comorbidity, associated functional impairments, and the risk and protective factors related to these disorders and impairments. The NJP addressed the patterns and sequences of the development of drug use and related variables, focusing on gender differences, racial/ethnic differences, the antecedents of these risky behaviors (risk and protective factors), and how these behaviors are interrelated.

The original sample included 1829 randomly selected youth, 1172 males and 657 females, then 10 to 18 years old, enrolled in the study as they entered the Cook County Juvenile Temporary Detention Center from 1995 to 1998. Among the sample were 1,005 African Americans, 524 Hispanics, 296 non-Hispanic white respondents. A random subsample of 997 of the baseline participants were chosen for second follow-up interviews. Researchers tracked participants from the time they left detention and re-interviewed them regardless of where they were living when their follow-up interview was due: in the community, correctional settings, or by telephone if they lived farther than two hours from Chicago.

The study was funded by OJJDP, several institutes at the National Institutes of Health, and other federal agencies and private foundations. The National Institutes of Health funded an additional component on HIV/AIDS risk behaviors.

Curated
Restricted

Northwestern Juvenile Project (Cook County, Illinois), Follow-up 3, 1999-2007 (ICPSR 36651)

Released/updated on: 2018-06-08
Geographic coverage: United States, Chicago, Illinois
Time period: 1977-01-01--2006-12-31

This study contains data from the third follow-up interview of the Northwestern Juvenile Project (NJP), a longitudinal assessment of alcohol, drug, or mental service treatment needs of juvenile detainees. The third follow-up occurred approximately four years after the baseline interview and focused on studying the development and persistence of psychiatric disorders, related predictive variables, patterns of drug use, and other risk behaviors.

The project's aims included studying (1) development and persistence of alcohol, drug, and mental disorders and (2) pathways and patterns of risky behaviors. Changes in disorders over time were studied (including onset, remission, and recurrence), comorbidity, associated functional impairments, and the risk and protective factors related to these disorders and impairments. This study addressed patterns and sequences of the development of drug use and related variables, focusing on gender differences, racial/ethnic differences, the antecedents of these risky behaviors (risk and protective factors), and how these behaviors were interrelated.

The original sample included 1829 randomly selected youth, 1172 males and 657 females, then 10 to 18 years old, enrolled in the study as they entered the Cook County Juvenile Temporary Detention Center from 1995 to 1998. Among the sample were 1005 African Americans, 524 Hispanics, 296 non-Hispanic white respondents. Participants were tracked from the time they left detention. A random subsample of 997 of the baseline participants were chosen for third follow-up interviews. Re-interviews were conducted regardless of where respondents were living when their follow-up interview was due: in the community, correctional settings, or by telephone if they lived farther than two hours from Chicago.

Curated
Restricted

Northwestern Juvenile Project (Cook County, Illinois), Follow-up 4, 2000-2006 (ICPSR 36686)

Released/updated on: 2018-06-08
Geographic coverage: United States, Chicago, Illinois
Time period: 1977-01-01--2006-12-31

This study contains data from the fourth follow-up interview of the Northwestern Juvenile Project (NJP), a longitudinal assessment of alcohol, drug, or mental service treatment needs of juvenile detainees. The fourth follow-up occurred approximately 4.5 years after the baseline interview and focused on studying the development and persistence of psychiatric disorders, related predictive variables, patterns of drug use, and other risk behaviors.

The project's aims included studying (1) development and persistence of alcohol, drug, and mental disorders and (2) pathways and patterns of risky behaviors. Changes in disorders over time were studied (including onset, remission, and recurrence), comorbidity, associated functional impairments, and the risk and protective factors related to these disorders and impairments. This study addressed patterns and sequences of the development of drug use and related variables, focusing on gender differences, racial/ethnic differences, the antecedents of these risky behaviors (risk and protective factors), and how these behaviors were interrelated.

The original sample included 1829 randomly selected youth, 1172 males and 657 females, then 10 to 18 years old, enrolled in the study as they entered the Cook County Juvenile Temporary Detention Center from 1995 to 1998. Among the sample were 1005 African Americans, 524 Hispanics, 296 non-Hispanic white respondents. Participants were tracked from the time they left detention. All participants were eligible for fourth follow-up interviews. Re-interviews were conducted regardless of where respondents were living when their follow-up interview was due: in the community, correctional settings, or by telephone if they lived farther than two hours from Chicago.

Curated
Restricted

Northwestern Juvenile Project, (Cook County, Illinois): Follow-up 1, 1998-2001 (ICPSR 34931)

Released/updated on: 2018-06-08
Geographic coverage: United States, Chicago, Illinois
Time period: 1977-01-01--2006-12-31

This study contains data from the first follow-up interview of the Northwestern Juvenile Project (NJP), a longitudinal assessment of alcohol, drug, or mental service treatment needs of juvenile detainees. This initial follow-up occurred approximately three years after the baseline interview and focused on studying the development and persistence of psychiatric disorders, related predictive variables, patterns of drug use, and other risk behaviors.

The project's aims included studying (1) development and persistence of alcohol, drug, and mental disorders and (2) pathways and patterns of risky behaviors. Changes in disorders over time were studied (including onset, remission, and recurrence), comorbidity, associated functional impairments, and the risk and protective factors related to these disorders and impairments. This study addressed patterns and sequences of the development of drug use and related variables, focusing on gender differences, racial/ethnic differences, the antecedents of these risky behaviors (risk and protective factors), and how these behaviors were interrelated.

The original sample included 1829 randomly selected youth, 1172 males and 657 females, then 10 to 18 years old, enrolled in the study as they entered the Cook County Juvenile Temporary Detention Center from 1995 to 1998. Among the sample were 1005 African Americans, 524 Hispanics, 296 non-Hispanic white respondents. Participants were tracked from the time they left detention. Re-interviews were conducted regardless of where respondents were living when their follow-up interview was due: in the community, correctional settings, or by telephone if they lived farther than two hours from Chicago.

Curated
Restricted

Johns Hopkins University Prevention Research Center - Risks for Transitions in Drug Use Among Urban Adults, Baltimore City, 2008-2011 (ICPSR 36622)

Released/updated on: 2017-10-13
Geographic coverage: Baltimore, United States, Maryland

The Johns Hopkins University Prevention Research center - Risks for Transitions, Baltimore city, 2008-2011 study (JHU PRC Risks for Transition in Drug Use among Urban Adults) represents data collected for a 25 years follow-up from the original JHU PRC study. At the start of the data collection, a cohort of 2,311 youth were randomly assigned to two classroom-based universal preventive interventions implemented in 43 classrooms of 19 public schools located in 5 socio-demographically distinct areas in Eastern Baltimore. This collection includes data from 1,434 respondents from the original cohort collected in 2008-2012. The mean age of the respondents was 30-32 years old.

Psychopathology (major depressive episode, phobia and anxiety disorders) was assessed using modules from the Composite International Diagnostic Interview-University of Michigan Version, CIDI- UM (WHO, 1997). An antisocial symptom scale adapted from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC) was administered which consisted of 30 questions that assessed behaviors experienced since turning 18 years of age. The alcohol, tobacco and drug modules of the interview were modeled after NESARC Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV. Types of information in these modules collected include age of onset, use in past year and prior past year, frequency and recency of use, and DSM-IV abuse and dependence criteria. Socioeconomic status indicators, variables on education, employment, marital status, parenthood, social supports, family history of mental health and drug problems, general health, treatment utilization, and life events are included in this dataset.

This dataset includes 3,140 variables.

Curated
Restricted

Addiction Health Evaluation and Disease (AHEAD) Management Study in Boston, Massachusetts, 2006-2010 (ICPSR 33581)

Released/updated on: 2017-03-31
Geographic coverage: United States, Massachusetts, Boston
Time period: 2006-09-01--2010-01-31

Substance dependence (SD) is a chronic disease that requires specialty drug and alcohol treatment, primary care (PC), and management of related problems. Although patients with SD may be linked with specialty care and PC, their health care often remains episodic and fragmented, rather than longitudinal, comprehensive, integrated, and coordinated. As a result, adults with SD often enter addiction treatment later and require acute medical care, rather than entering the system earlier when interventions of lower intensity but longer duration might prevent catastrophes. Chronic disease management (CDM) is a collaborative, longitudinal approach to treatment of certain chronic medical illnesses proven to be more effective than routine care. CDM addresses individual patient and health systems barriers to receipt of needed treatment. However, the effectiveness of CDM for SD has not been tested. The objective of this Addiction Health Evaluation and Disease management (AHEAD) study, was to test the effectiveness of CDM for SD in PC.

Subject identification and recruitment occurred primarily at a local detoxification center, as well as by self and physician referral from the Boston Medical Center primary and ambulatory care clinics, emergency department, urgent care center, inpatient settings, and the community. The study enrolled 320 adults with drug dependence and 320 adults with alcohol dependence who were not in SD treatment, and randomized them to a SD CDM program (the AHEAD Clinic) integrated into a real-world PC clinic or to referral to standard PC. All subjects were assessed regarding SD diagnosis, substance use and problems, readiness to change, health-related quality of life, and medical and drug treatment utilization. Subjects were evaluated 3, 6, and 12 months later, and health services utilization data were collected for 2 years from a statewide database. Additionally, in order to better understand and explain the implementation and fidelity of the AHEAD Clinic, the primary care providers (PCPs) of AHEAD Clinic patients were surveyed. Each PCP was presented with a letter from the Principal Investigator explaining the purpose of the survey, the reason why s/he was being asked to complete the survey, compensation for completing the survey, and details about confidentiality and anonymity. The survey itself consisted of questions asking providers about their satisfaction and their attitudes towards caring for patients with alcohol and drug problems, their knowledge of services that the AHEAD Clinic provides, and their experience working with the AHEAD Clinic.

Primary outcomes were illicit drug use, alcohol use, substance-related problems, emergency department visits, and hospitalizations. The proposal's hypothesis was that compared with standard care, a health services delivery intervention (CDM for SD integrated in PC) would decrease alcohol and illicit drug use and related problems, and improve health care utilization patterns. Improved outcomes using the AHEAD approach would support the adoption of a health services delivery strategy, CDM, to better care for patients with SD.

  • Dataset 1: 844 variables; 563 cases
  • Dataset 2: 607 variables; 500 cases
  • Dataset 3: 607 variables; 487 cases
  • Dataset 4: 713 variables; 532 cases
  • Dataset 5: 80 variables; 549 cases
  • Dataset 6: 59 variables; 1,435 cases
  • Dataset 7: 25 variables; 87 cases
  • Dataset 8: 25 variables; 87 cases
  • Dataset 9: 41 variables; 73 cases
  • Dataset 10: 9 variables; 11,018 cases
  • Dataset 11: 5 variables; 511 cases
Curated
Restricted

California Families Project [Sacramento and Woodland, California] [Restricted-Use Files] (ICPSR 35476)

Released/updated on: 2017-03-08
Geographic coverage: Sacramento, United States, California
Time period: 2006-01-01--2007-12-31

The California Families Project (CFP) is an ongoing longitudinal study of Mexican origin families in Northern California. This study uses community, school, family, and individual characteristics to examine developmental pathways that increase risk for and resilience to drug use in Mexican-origin youth. This study also examines the impact that economic disadvantage and cultural traditions have in Mexican-origin youth. The CFP includes a community-based sample of 674 families and children of Mexican origin living in Northern California, and includes annual assessments of parents and children. Participants with Mexican surnames were drawn at random from school rosters of students during the 2006-2007 and 2007-2008 school year. Data collection included multi-method assessments of a broad range of psychological, familial, scholastic, cultural, and neighborhood factors. Initiation of the research at age 10 was designed to assess the focal children before the onset of Alcohol, Tobacco, and Other Drug (ATOD) use, thus enabling the evaluation of how hypothesized risk and resilience mechanisms operate to exacerbate early onset during adolescence or help prevent its occurrence. This study includes a diversity of families that represent a wide range of incomes, education, family history, and family structures, including two-parent and single-parent families.

The accompanying data file consists of 674 family cases with each case representing a focal child and at least one parent (Two-parent: n=549, 82 percent; Single-parent: n=125, 18 percent). Of the 3,139 total variables, 839 pertain to the focal child, 1,376 correspond to the mother, and 908 items pertain to the father.

Please note: While the California Families Project is a longitudinal study, only the baseline data are currently available in this data collection.

Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2014 (ICPSR 36361)

Released/updated on: 2016-03-22
Geographic coverage: United States
Time period: 2014-01-01--2014-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2014 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2008 (ICPSR 26701)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2008-01-01--2008-12-31

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.

Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2007 (ICPSR 23782)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2007-01-01--2007-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2009 (ICPSR 29621)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2009-01-01--2009-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2012 (ICPSR 34933)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2012-01-01--2012-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2012 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2010 (ICPSR 32722)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2010-01-01--2010-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2010 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2011 (ICPSR 34481)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2011-01-01--2011-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2013 (ICPSR 35509)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2013-01-01--2013-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2013 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2005 (ICPSR 4596)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2005-01-01--2005-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2005 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2003 (ICPSR 4138)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2003-01-01--2003-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2003 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. A number of additional questions were added in 2003, including questions on prior marijuana and cigarette use, additional questions on drug treatment, adult mental health services, and social environment.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2002 (ICPSR 3903)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2002-01-01--2002-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey includes questions concerning treatment for both substance abuse and mental health related disorders. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2002 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2002 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2004 (ICPSR 4373)

Released/updated on: 2015-11-23
Geographic coverage: United States
Time period: 2004-01-01--2004-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2004 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2004 Adult and Adolescent Mental Health modules were added.
Curated

Drug Abuse Warning Network (DAWN), 1997: [United States] (ICPSR 2834)

Released/updated on: 2014-08-13
Geographic coverage: United States
Time period: 1997-01-01--1997-12-31
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated

Drug Abuse Warning Network (DAWN), 1994: [United States] (ICPSR 2756)

Released/updated on: 2014-08-13
Geographic coverage: United States
Time period: 1994-01-01--1994-12-31
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated
Restricted

Strategic Prevention Framework State Incentive Grant (SPF SIG) National Cross-Site Evaluation [Restricted Use] (ICPSR 28921)

Released/updated on: 2014-03-24
Geographic coverage: North Carolina, Vermont, Indiana, United States, Wyoming, Tennessee, Maine, Arkansas, Washington, West Virginia, Colorado, Missouri, Guam, Arizona, Nevada, Rhode Island, Montana, Kentucky, Florida, Michigan, New Mexico, Illinois, Texas, Connecticut, New Hampshire, Louisiana, Palau
Time period: 2005-08-01--2007-09-30, 2006-12-14--2007-08-14, 2008-09-15--2009-06-30, 2008-10-15--2009-06-15, 2006-07-01--2006-09-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30
The Strategic Prevention Framework State Incentive Grant (SPF SIG) National Cross-Site Evaluation was conducted to evaluate the Center for Substance Abuse Prevention (CSAP)'s SPF SIG initiative, which sought to: (1) prevent the onset and reduce the progression of substance abuse, including childhood and underage drinking; (2) reduce substance abuse-related problems in communities; and (3) build prevention capacity and infrastructure at the state and community levels. This cross-site evaluation included the 21 states and territories CSAP funded in FY2004 (Cohort 1) and an additional 5 States funded in Cohort 2 in FY2005 that were funded for up to 5 years to implement the SPF. The SPF is a five-step prevention planning model that requires states to: (1) conduct a statewide needs assessment, including the establishment of a State Epidemiological and Outcomes Workgroup (SEOW); (2) mobilize and build state and community capacity to address needs; (3) develop a statewide strategic plan for prevention; (4) implement evidence-based prevention, policies, and practices (EBPPP) to meet state and community needs; and (5) monitor and evaluate the implementation of their SPF SIG project. Under contract to the Substance Abuse and Mental Health Services Administration (SAMHSA) with funding provided by the National Institute on Drug Abuse (NIDA), Westat, in collaboration with the Pacific Institute for Research and Evaluation (PIRE) and The MayaTech Corporation, implemented a multilevel, multi-method quasi-experimental design to evaluate SPF SIG's impact. The scope of the evaluation encompassed national, state, and community levels. The design included comparison conditions at both the state and community levels. These data represent Phase I of the restricted use data release and contains extensive data on state-level implementation, community-level implementation, and state-level infrastructure, as well as other reference elements. A subsequent release (Phase II) will include state- and community-level outcomes, as well as data on community-level implementation, community-level implementation fidelity, state-level sustainability, and mediating variables.
Curated
Restricted

Dynamics of Retail Methamphetamine Markets in New York City, 2007-2009 (ICPSR 29821)

Released/updated on: 2014-01-06
Geographic coverage: New York City, United States, New York (state)
Time period: 2007-01-01--2009-12-31
The study was conducted to provide information about markets for, distribution of, and use of methamphetamine in New York City, both inside and outside of the MSM (men who have sex with men)/gay community. The study used Respondent Driven Sampling to recruit 132 methamphetamine market participants. Each respondent participated in a one to two hour structured interview combining both qualitative and quantitative responses. Each respondent was invited to recruit three additional eligible participants. Data collected included demographics, social network data, the respondent's market participation in obtaining and providing methamphetamine, consumption of methamphetamine, and experience with the criminal justice system and crime associated with participation in methamphetamine markets.
Curated
Restricted

Northwestern Juvenile Project (Cook County, IL): Baseline, 1995-1998 [Restricted] (ICPSR 32603)

Released/updated on: 2013-08-30
Geographic coverage: United States, Illinois
Time period: 1995-01-01--1998-12-31

Established in 1995, the Northwestern Juvenile Project assessed alcohol, drug, or mental (ADM) service needs of juvenile detainees. The study took place between the years of 1995 and 1998, sampling 1,829 male and female juvenile detainees within Cook County, Illinois. This study had two specific aims:

  1. To assess the juvenile detainees ADM service needs (including psychiatric disorder, comorbidity and functional impairment); and,
  2. To determine the extent that juvenile detainees who need ADM services received them while in the custody of the criminal justice system.

This study has four methodological advantages over prior research:

  1. Stratified random sampling;
  2. Sufficiently large N (approximately 600 females and 1200 males);
  3. Reliable instruments; and
  4. Comorbidity data.

Questions for respondents generally pertain to demographics, medical and sexual history, criminal history, aptitude and mental health assessment, familial and social relations, drug abuse, and education.

Curated

National Household Survey on Drug Abuse, 2000 (ICPSR 3262)

Released/updated on: 2013-06-25
Geographic coverage: United States
Time period: 2000-01-01--2000-12-31
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2000 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained in the 2000 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 2001 (ICPSR 3580)

Released/updated on: 2013-06-25
Geographic coverage: United States
Time period: 2001-01-01--2001-12-31
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2001 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2001 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2001 questions on purchase of marijuana were added.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2006 (ICPSR 21240)

Released/updated on: 2013-06-21
Geographic coverage: United States
Time period: 2006-01-01--2006-12-31
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2006 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

Variations in Criminal Patterns Among Narcotic Addicts in Baltimore and New York City, 1983-1984 (ICPSR 9586)

Released/updated on: 2013-05-15
Geographic coverage: New York City, Baltimore, United States, New York (state), Maryland
Time period: 1983-05-01--1984-04-30
This data collection was undertaken to develop a typology of narcotic addicts according to the kind, frequency, and seriousness of their crimes and to identify the most serious criminal offenders, thereby determining which individuals were best suited to rehabilitation. The following questions are addressed by the data: (1) What "types" of narcotic addicts can be distinguished in terms of their criminal behavior? Which of these types are amenable to rehabilitation? (2) At what time during their addiction careers do addicts commit the most crime? Do narcotic addicts "mature" out of addiction? (3) What is the relationship between individuals' involvement in crime prior to addiction and their criminal activity and drug use over their addiction career? (4) Which demographic, personality, or other factors are associated with serious crime committed during periods of narcotic addiction? (5) What are the contributions of situational and dispositional factors to the relationship between addiction and crime? Part 1 of the collection details the subjects' addiction careers, the age they first used various drugs, the age they first became addicted to narcotics, the amount of time they were addicted/not addicted to narcotics, and the total length of their addiction careers. Part 2 contains variables generated by cluster analysis, including cluster assignment or "type." Part 3 includes the educational, occupational, and arrest histories of the subjects, as well as the drug use and arrest histories of their families. The Part 4 file consists of Minnesota Multiphasic Personality Inventory and Raven Progressive Matrix scores. The frequency and types of crime that subjects committed during the preaddiction period comprise Part 5, while the frequency and nature of drug use during the preaddiction period comprise Part 6. Parts 7 and 8 contain crime variables and drug use variables, respectively, across all nonaddiction periods. Finally, Part 9 contains data characterizing crime across all addiction periods, and Part 10 contains variables regarding drug use across total addiction periods.
External data

NIDA Genetics Consortium (ICPSR 34547)

Released/updated on: 2013-01-24

The NIDA Genetics Consortium was created in 1999 and has several overarching missions: (1) identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction; (2) create a repository for data (i.e., clinical information and biospecimens containing DNA; (3) generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access to collaborative studies with the broader scientific community; and (4) establish a consortium of scientists who meet regularly and collaborate on projects.

Along with the description of the NIDA Genetics Consortium, the Web site outlines policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability.

Curated
Restricted

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)

Released/updated on: 2012-08-22
Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)
Time period: 1995-01-01--1996-12-31
This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.
Curated
Restricted

Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)

Released/updated on: 2011-11-04
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2010-01-01--2010-12-31
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted

National Survey of Parents and Youth (NSPY), 1998-2004 -- Restricted Use Files (ICPSR 27868)

Released/updated on: 2011-03-07
Geographic coverage: United States
Time period: 1998-01-01--1998-06-30, 1998-07-01--1999-07-31, 1999-11-01--2004-06-30
The National Survey of Parents and Youth (NSPY) is a survey conducted to evaluate the National Youth Anti-Drug Media Campaign (Campaign). It focuses on the measurement of the outcomes and impact of Phase III of the Campaign on children and their parents concerning illegal drug use among youth. It contains four rounds of Restricted Use Files and includes all NSPY respondents. The Restricted Use Files also contain extensive data on youth, parents, and the Campaign advertisements, as well as other reference files. In addition, NSPY contains Public Use Files which were released in September 2004. The Public Use Files contain only the first three rounds of data and a subsample of respondents. Also, due to confidentiality reasons, the September 2004 Public Use File provides a limited set of variables about youth, and only a handful of variables about parents as it is not possible to link respondents across rounds using the Public Use Files, but it is possible using the Restricted Use Files. The survey was developed and implemented under contract to the National Institute on Drug Abuse (NIDA). Westat conducted the study in collaboration with the Annenberg School for Communication at the University of Pennsylvania and, for the first two years of the project, with the National Development and Research Institutes, Inc. (NDRI). NSPY Round 1 was conducted in three waves, covering the periods November 1999 through May 2000 (Wave 1), July 2000 through December 2000 (Wave 2), and January 2001 through June 2001 (Wave 3). NSPY Round 2, the first follow-up of the initial survey, was conducted in two waves covering the periods July 2001 through December 2001 (Wave 4) and January 2002 through June 2002 (Wave 5). NSPY Round 3, the second follow-up data collection, was conducted in two waves covering the periods July 2002 through December 2002 (Wave 6) and January 2003 through June 2003 (Wave 7). Finally, NSPY Round 4, the third follow-up data collection, was conducted in two waves covering the periods July 2003 through December 2003 (Wave 8) and January 2004 through June 2004 (Wave 9). Youths and their parents were selected for NSPY through a multistage, dual frame probability sample design. The sample was selected in a manner designed to provide an efficient and representative cross-section of American youth. In general, youths living in all types of residential housing units were eligible for the study; however, youths living in institutions, group homes, or dormitories were excluded.
Curated
Restricted

Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)

Released/updated on: 2011-02-24
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2009-01-01--2009-12-31
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted

Arrestee Drug Abuse Monitoring (ADAM) Project in Rural Nebraska, 1998 (ICPSR 28141)

Released/updated on: 2011-01-28
Geographic coverage: Omaha, United States, Nebraska
Time period: 1998-10-01--1998-11-30
A pilot outreach project of the National Intstitute of Justice's Arrestee Drug Abuse Monitoring (ADAM) program, the rural Nebraska ADAM program examined the prevalence and type of arrestee drug use in four rural Nebraska counties and compared the results to those found in Omaha, Nebraska, an established ADAM site. The data were collected in Madison (n=78), Dawson (n=50), Hall (n=53), and Scotts Bluff (n=149) counties, and Omaha, Nebraska, (n=202) in October and November of 1998. The catchment area for Omaha was the central city. The ADAM interview provided demographic and descriptive data, including race, age, marital status, source of income, screens of substance abuse and dependency, treatment history, arrest and incarceration experiences, and participation in local drug markets. At the conclusion of the interview, respondents were asked to provide a urine specimen. The current study included a supplemental questionnaire about methamphetamine use. The methamphetamine addendum included variables on why the respondent began and continued the use of methamphetamines, how often and how much methamphetamine was used, if and why the respondent had ever sought and completed treatment, source of the methamphetamine, and if the respondent had ever made or sold methamphetamine.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Inmate Pre-Release Assessment (IPASS), 2001 [United States] (ICPSR 29201)

Released/updated on: 2011-01-06
Geographic coverage: Oregon, United States, New Mexico, California, Maryland
Time period: 2001-05-01--2001-07-31
The UCLA Integrated Substance Abuse Programs (ISAP), in conjunction with Texas Christian University, the University of Kentucky, and Brown University, proposes to develop and test the Inmate Pre-Release Assessment (IPASS) as a method of (1) prioritizing aftercare treatment need among graduates of prison-based substance abuse treatment programs, and (2) specifying an appropriate level of care (residential, outpatient, or self-help groups). The IPASS was developed specifically as a post-release risk measure for prison-based substance abuse treatment graduates by taking into account the inmates' historical drug use and criminal activity, as well as his or her performance during the prison-based treatment program. IPASS forms were administered to inmates housed in 14 institutions in four states: California, Maryland, New Mexico, and Oregon. While the IPASS has demonstrated sound psychometric properties as a continuous measure of post-release risk and general treatment need for substance-abusing parolees (Farabee & Knight, 2001), its ability to predict relapse and recidivism risk has not been tested using a prospective design. Part 1 of this study is the main part which is based on the IPASS Intake Form (479) and is designed to provide a quick assessment of criminal risk based on pre-incarceration risk factors. The first part of this form focuses heavily on criminal history, with questions about arrest and incarceration history, revocation history, and age of first criminal activity. It also asks about education level achieved, marital status and happiness, and friends drug use. The next part on the IPASS Intake Form (479) is designed to provide a quick screen for pre-incarceration drug use severity. It is based on the first ten items of the TCU Drug Screen II with the items corresponding to Diagnostic and Statistical Manual (DSM) classification criteria for Drug Dependence. And the last part of the IPASS Intake form begins by asking inmates if they want to enter a drug treatment program after leaving prison; and if so, which treatment modality is preferred. Inmates were asked to indicate how much they disagree or agree with nine items pertaining to their interactions with the treatment staff. These items include the treatment staff being easy to talk to, easy to understand, listening to you, organized and prepared, treating you with respect, helping you solve problems, supportive of your progress, helping you with your recovery, and happy with your progress. Part 2 of the study mainly focused on arrest information and the number of criminal activities. Part 3 of the study is based on the IPASS Continuing Care Referral Form (484) and begins by asking inmates if they want to enter a drug treatment program after leaving prison; and if so, which treatment modality is preferred. Part 4 of the study is based on the IPASS Continuing Care Admit/Discharge Form (481A) and provides information regarding the Admission and Discharge of the inmates. And finally, Part 5 of the study is completed by the inmates' primary counselor and begins by recording the number of "major" disciplinary acts an inmate committed prior to and during their time at the treatment program.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Program (NCJTP) Survey in the United States, 2002-2008 (ICPSR 27382)

Released/updated on: 2010-08-09
Geographic coverage: District of Columbia, United States
Time period: 2002-01-01--2008-12-31
The National Criminal Justice Treatment Practices (NCJTP) Survey provides a comprehensive inquiry into the nature of programs and services provided to adult and juvenile offenders involved in the justice system in the United States. Participants included key criminal justice administrators, operations managers, and staff. This survey was conducted in all 50 states and the District of Columbia. The survey involved a myriad of state, regional, and local organizations employing a mix of their own staff and contracted personnel, and services that might involve multiple levels of government. It was a self-administrated, paper-and-pencil questionnaire. The methodology included a multilevel approach that captured the perspective of executives, front-line administrators, and line staff about current practices in a range of institutional and community correctional settings for adults and juveniles. The goals for this survey were: to describe current drug treatment practices, policies, and delivery systems for offenders on probation or parole supervision, and in jails, prisons, and youth institutions; to examine agency structures, resources, and other organizational factors that may affect service delivery, including mission, leadership, climate, culture, and beliefs about rehabilitation versus punishment; and to assess coordination and integration across criminal justice agencies and between corrections and treatment systems. Items in the survey included: respondent characteristics, organizational characteristics, correctional programs characteristics (e.g., size, nature, etc.), substance abuse treatment programs characteristics, social networks/agencies collaboration, integration of services with other agencies, attitudes toward punishment and rehabilitation (personal values), organizational needs assessment, organizational culture and climate for treatment, cynicism toward change, organizational commitment to treatment, and perspectives on intradepartmental coordination.
Back to top